Although such a small improvement in survival time might not be significant at the individual level, it provides evidence at the population level to guide CMD patients to enhance health monitoring and cancer screening.
← all excerpts
Multiomics insight into disease trajectories of cardiometabolic diseases and cancer.
1
—
—